Home > News > Nanogen Issued Patent for Electronic Devices
May 5th, 2004
Nanogen Issued Patent for Electronic Devices
Nanogen, Inc., developer of molecular and point-of-care diagnostic products, announced today that it was issued U.S. Patent No. 6,726,880, "Electronic Devices for Performing Active Biological Operations and Method of Using Same," by the U.S. Patent and Trademark Office. The '880 patent relates to new devices that enable increased sensitivity of active, programmable electronic matrix (APEX) devices and perform actions such as concentration and assembly of biological materials on a substrate.
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014